Human Health and Disease · Lesson 7 of 11
HIV Infection, AIDS and the Immune System
“Transmission, reverse transcription, integration, CD4 T-cell depletion, diagnosis, antiretroviral treatment and prevention.”
• Differentiate HIV infection from advanced immunodeficiency or AIDS. • Trace HIV replication in a susceptible host cell from entry through particle maturation. • Explain how progressive CD4 T-cell loss weakens several immune pathways. • Identify established transmission routes and routes that do not transmit HIV. • Explain the modern biological role of antiretroviral treatment and prevention.
HIV infection and AIDS are related but not interchangeable
Human immunodeficiency virus, HIV, is an enveloped retrovirus with an RNA genome. AIDS stands for acquired immunodeficiency syndrome and describes an advanced clinical condition that can develop from inadequately treated HIV infection. A person can have HIV without having AIDS, particularly when diagnosed early and receiving effective treatment. AIDS is not a separate organism and is not inherited as a congenital genetic disorder. The main biological mechanism involves viral infection of certain immune cells, especially CD4 helper T lymphocytes, with progressive damage to immune coordination when the infection is not controlled.
Transmission requires relevant infected body fluids
HIV may be transmitted through certain sexual exposures, shared contaminated injection equipment, unsafe blood products or certain clinical exposures, and from parent to child during pregnancy, delivery or breastfeeding. These routes require infected bodily fluids and an appropriate pathway into susceptible tissue or bloodstream. Ordinary social contact such as shaking hands, hugging, sharing meals, using the same classroom or sharing toilets does not transmit HIV. Mosquito bites do not transmit HIV. Transmission should therefore be described biologically, without attributing infection to a person's identity or making assumptions about behaviour.
Screened blood supplies, sterile needles, appropriate barrier methods and effective HIV prevention medicines reduce transmission. For people without HIV who have ongoing risk, pre-exposure prophylaxis, or PrEP, is a preventive option assessed through healthcare services. After a substantial possible exposure, post-exposure prophylaxis, or PEP, requires urgent medical assessment and is most useful when initiated as soon as possible, no later than 72 hours under standard guidance. These approaches supplement testing, counselling and prevention of unsafe blood or injection exposure.
HIV uses an RNA-to-DNA replication pathway
HIV attaches to susceptible host-cell receptors, typically involving CD4 and a relevant coreceptor, and enters the cell by membrane fusion. The viral RNA and enzymes are released inside. The enzyme reverse transcriptase synthesises DNA from the RNA template; this is the characteristic reverse direction relative to the common DNA-to-RNA transcription pathway. Viral integrase then enables viral DNA to become inserted into the host cell's chromosomes, creating an integrated provirus. The host cell's transcriptional and translational machinery can produce viral RNA and proteins from this integrated genetic information.
New viral RNA and proteins gather at cellular membranes and assemble into particles that bud from the host. Viral protease processes precursor proteins during maturation, allowing particles to become fully infectious. This sequence explains why HIV is called a retrovirus and why several antiviral drugs target distinct stages: reverse transcription, integration, protease activity and other processes. Viral replication can occur in CD4 T-cell populations and cells of the monocyte–macrophage lineage, with effects depending on the infected cell and tissue environment.
Why CD4 T-cell depletion causes immunodeficiency
CD4 helper T lymphocytes coordinate important parts of adaptive immunity. They help activate certain B-cell antibody responses, influence macrophages and participate in the formation of cellular immunity. Untreated HIV can progressively decrease the number and effective function of CD4 cells through several direct and indirect mechanisms. This makes it more difficult to control pathogens that are normally restrained by a healthy immune system. Opportunistic infections, including particular fungal, bacterial, protozoal and viral diseases, can occur as immune competence falls.
Symptoms in untreated HIV infection can vary from no noticeable illness to fever, weight loss, diarrhoea and other manifestations. An early asymptomatic interval does not mean the virus is absent, and the time to advanced disease is not identical for every person. AIDS is usually defined using established clinical or immunological criteria rather than by the presence of HIV alone. The immune mechanism is a progressive loss of coordinated defence; the organism is not simply a toxin that destroys all white blood cells at once.
Diagnosis and modern treatment
Laboratory diagnosis relies on appropriate HIV antigen/antibody and confirmatory testing algorithms, with HIV RNA tests useful in selected circumstances. The source mentions enzyme-linked immunosorbent assay, or ELISA, as a traditional laboratory method, but modern testing often uses combined antigen–antibody assays and further confirmation rather than one result in isolation. The timing of infection affects detectability, so testing plans account for the time since possible exposure. Testing and linkage to care should be confidential and free of stigma.
Modern antiretroviral therapy, or ART, uses combinations of drugs that suppress HIV replication. It cannot routinely eliminate all persistent viral reservoirs, but sustained treatment can maintain very low viral loads and greatly reduce the chance of immune destruction and opportunistic disease. People with effective long-term treatment may live for many decades. A person who maintains an undetectable viral load through ART does not sexually transmit HIV, an evidence-based principle often expressed as undetectable equals untransmittable, or U=U. This applies to sexual transmission under the stated condition and should not be generalised automatically to every possible exposure route.
The source's older conclusion that death remains inevitable despite antiretroviral treatment is scientifically outdated and should not be repeated as a current fact. It also overstates the absence of preventive options by omitting modern ART-based strategies. HIV is a manageable chronic infection for many people with reliable care, though access, drug resistance, adherence and coexisting illnesses still affect outcomes. Prevention includes reducing exposure, using sterile equipment, screening blood, treating infection effectively and providing appropriate preventive medicines.
| Term | Meaning | Biological significance |
|---|---|---|
| HIV | Human immunodeficiency virus | Retrovirus that infects susceptible immune cells |
| AIDS | Acquired immunodeficiency syndrome | Advanced condition of immune dysfunction |
| Reverse transcriptase | Viral RNA-dependent DNA polymerase | Creates viral DNA from viral RNA |
| Integrase | Viral enzyme | Inserts viral DNA into host DNA |
| CD4 helper T cell | Immune coordinating lymphocyte | Loss impairs multiple responses |
| ART | Antiretroviral therapy | Suppresses viral replication |
| U=U | Undetectable equals untransmittable | Sustained viral suppression prevents sexual HIV transmission |
Quick Quiz
Quiz
Which is the correct relationship between HIV and AIDS?
What does reverse transcriptase do in HIV replication?
Why is HIV integration biologically important?
Which immune cells are especially affected during progression toward AIDS?
Which interaction does not transmit HIV?
What is an established effect of sustained undetectable viral load on sexual transmission?
Which prevention option is considered urgently after a substantial potential HIV exposure?
Practice Problems
- Trace the HIV replication sequence and show where reverse transcriptase and integrase act.
- Explain how HIV infection can lead to susceptibility to opportunistic infections.
- Classify established HIV transmission routes and explain why everyday social contact is safe.
- Compare the older untreated-HIV outcome with what effective antiretroviral therapy can achieve.
- Distinguish PrEP, PEP, screening and ART by when and why each is used.
HIV binds suitable receptors including CD4 and a coreceptor, fuses with the host-cell membrane and releases its RNA and enzymes. Reverse transcriptase copies the viral RNA into DNA, and integrase helps insert that DNA into host chromosomes. The integrated sequence can be transcribed and translated by cellular machinery, making new viral RNA and proteins. Particles assemble, bud from the membrane and mature through viral protease processing. This explains why antiretroviral drug combinations target several different replication steps.
Key Takeaways
• HIV is an RNA retrovirus; AIDS is an advanced syndrome of immune deficiency. • HIV reverse transcriptase makes DNA from RNA, and integrase inserts it into host DNA. • CD4 helper T-cell dysfunction weakens multiple immune pathways. • HIV is transmitted through specific exposures to infectious fluids, not ordinary social contact. • Testing uses modern antigen–antibody and confirmatory algorithms. • ART suppresses viral replication and can support long-term health. • Sustained undetectable viral load prevents sexual HIV transmission. • PrEP and timely PEP are additional prevention approaches.